Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Regeneron posts phase 3 win, advancing push to muscle in on gMG
Regeneron plans to file for FDA approval of its siRNA candidate in the increasingly competitive generalized myasthenia gravis market.
Nick Paul Taylor
Aug 26, 2025 9:41am
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
Aug 26, 2025 6:45am
Akeso scores twice in phase 3, tees up regulatory submission
Aug 25, 2025 1:37pm
PDS reports 39 months OS in phase 2 head and neck cancer trial
Aug 25, 2025 9:00am
Dynavax's vaccine holds its own against Shingrix in early test
Aug 21, 2025 8:00am
FDA draft recommends all cancer trials collect OS data
Aug 20, 2025 10:59am
